Rashi Raghulan

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Revolution Medicines (United States)(Current)

Rashi Raghulan is an author at Revolution Medicines (United States) specializing in ras signaling pathway, cancer progression, and cancer cell signaling.

Publications per year

2024–2025

Publications

Mechanisms of Response and Tolerance to Active RAS Inhibition in <i>KRAS</i> -Mutant Non–Small Cell Lung Cancer

Haniel A. Araújo, Ximo Pechuan-Jorge, Teng Zhou et al. · Cancer Discovery · 2024 · 65 citations · Full text

Medicine, Oncology, Pharmacology +17

A RAS(ON) Multi-Selective Inhibitor Combination Therapy Triggers Long-term Tumor Control through Senescence-Associated Tumor-Immune Equilibrium in Pancreatic Ductal Adenocarcinoma

Caroline Broderick, Riccardo Mezzadra, Exequiel M. Sisso et al. · Cancer Discovery · 2025 · 15 citations · Full text

Medicine, Immunology, Oncology +17

1–2 of 2